Home Newsfeeds JP Morgan Downgrades InterContinental Hotels to Neutral

JP Morgan Downgrades InterContinental Hotels to Neutral

JP Morgan analyst Estelle Weingrod downgrades InterContinental Hotels (NYSE:IHG) from Overweight to Neutral.

byBenzinga Newsdesk

August 26, 2022

1 minute read

JP Morgan analyst Estelle Weingrod downgrades InterContinental Hotels (NYSE:IHG) from Overweight to Neutral.

Apple’s WWDC 2024 OpenAI Tie-Up Moves Could Be Replicated In China Via Alibaba, Baidu, Says Gene Munster

By Benzinga Neuro

June 10, 10:18 PM

Apple could potentially partner with Chinese tech giants Baidu and Alibaba Group Holding for its AI features in China, according to tech analyst Gene Munster.

AAPL

AMD Falls On Q1 Earnings, Q2 Guidance: Why ‘1,000% Growth’ From AI Stock Is Not Enough For Investors

By Chris Katje

May 1, 12:39 PM

AMD raised its guidance for AI segment growth, but it wasn't enough to send shares higher after Q1 results. Analysts size up the results and guidance.

AMD

Analyst Ratings

9 Analysts Have This to Say About Paycom Software

By Benzinga Insights

April 28, 8:01 AM

Analysts have provided the following ratings for Paycom Software (NYSE:PAYC) within the last quarter: Bullish Somewhat Bullish Indifferent…

PAYC

Analyst Ratings

What 7 Analyst Ratings Have To Say About Rhythm Pharmaceuticals

By Benzinga Insights

August 3, 1:22 PM

Over the past 3 months, 7 analysts have published their opinion on Rhythm Pharmaceuticals (NASDAQ:RYTM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

RYTM

JP Morgan Downgrades InterContinental Hotels to Neutral

Related Posts

Apple’s WWDC 2024 OpenAI Tie-Up Moves Could Be Replicated In China Via Alibaba, Baidu, Says Gene Munster

AMD Falls On Q1 Earnings, Q2 Guidance: Why ‘1,000% Growth’ From AI Stock Is Not Enough For Investors

9 Analysts Have This to Say About Paycom Software

What 7 Analyst Ratings Have To Say About Rhythm Pharmaceuticals